Njord Medtech
Making moving patients easier
- CEO: Jacob Ahrnstein
 - First investment year: 2022
 - Fund: Västsverige
 - Business sector: Life Science
 
      Njord develops medtech products to improve productivity at hospitals. Its patented motorized patient transfer device – Atle – makes horizontal lifting or moving of patients easier. Additionally, a new solution to facilitate supine to prone position improving patient oxygenation and a digital application to support cancer patients are under development.